Back to results
US 2023/0416733 A1Published application
Guide rna with chemical modifications
AssigneeAgilent Technologies, Inc.
InventorsDaniel E. RYAN, Douglas J. DELLINGER, Jeffrey R. SAMPSON, Robert KAISER, Joel MYERSON
Life of this patent
Estimating the term…
Abstract
The present invention relates to modified guide RNAs and their use in clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems.
Claims30
A chemically-synthesized single molecule CRISPR guide RNA (gRNA) comprising:
- a 5′-end and a 3′-end;
- one or more chemically modified nucleotides within five nucleotides from said 5′-end or said 3′-end, or within five nucleotides from each of said 5′-end and said 3′-end, wherein each of the one or more chemically modified nucleotides is independently selected from 2′-O-methyl-3′-phosphorothioate (MS), 2′-O-methyl-3′-phosphonoacetate (MP), and 2′-O-methyl-3′-thiophosphonoacetate (MSP);
- a guide sequence that is 18-22 nucleotides long and is capable of hybridizing to a target sequence in a target polynucleotide;
- and
- a scaffold region that can interact with a Cas9 protein to form a gRNA:Cas9 complex, wherein said complex is capable of cleaving both strands of the target polynucleotide when the Cas9 protein has double-strand nuclease activity.
2 more elements
Dependencies are inferred from the claim text.